Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Lumiphore Inc. is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This workload is concentrated under 1 distinct examiner and 1 distinct art unit, which suggests a specific technical niche for the company's pending applications. Having 1 distinct examiner means that the prosecution strategy can be tailored to the specific preferences and history of that individual. This focus can lead to efficient communication during the patent acquisition process.
The busiest examiner for Lumiphore Inc. is FERGUSON, JALISA HOLMES, who is assigned the 1 busiest examiner pending office action. This examiner is the official currently reviewing the company's pending work, so their interpretation of the prior art is paramount. With 1 distinct art unit involved, the company is subject to the specific examination guidelines of that group. Resolving the 1 pending office action will require a direct and focused response to the concerns raised by the 1 distinct examiner to ensure the biotechnology claims are granted.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FERGUSON, JALISA HOLMES | 1 | 61.1% | +43.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18250096 | THIOHYDROXYPYRIDINE CHELATES | FERGUSON, JALISA HOLMES | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18250096 | THIOHYDROXYPYRIDINE CHELATES | FERGUSON, JALISA HOLMES | 1626 | §102§103§112DP | Non-Final OA | — | Pending | Apr 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial